Overview

Update
Total Equity Funding
$107.62M in 2 Rounds from 7 Investors
Most Recent Funding
$37M Series B on September 8, 2015
Headquarters:
Cambridge, MA
Description:
Proteostasis Therapeutics discovers and develops novel small molecule therapeutics to control the body's protein homeostasis.
Categories:
Therapeutics, Biotechnology, Medical
Website:
http://www.proteostasis.com

Company Details

Update

Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.

Funding Rounds (3) - $110.64M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2015$37M / Series B7
Aug, 2014$3.01M / Debt Financing0
Aug, 2008$70.62M / Series A5

Current Team (2)

Update

Board Members and Advisors (3)

Update

Offices/Locations (1)

Update
  • Office

    790 Memorial Drive, Suite 103

    Cambridge, MA 02139

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos